Dr. Joseph Chang Launches Update to Bestselling Book "The Aging Myth" With 15 More Years of Breakthrough Research on Cellular Wellness
MWN-AI** Summary
Dr. Joseph Chang, chair of the Nu Skin Scientific Advisory Board, has relaunched his bestselling book, "The Aging Myth: Unlocking the Mysteries of Looking and Feeling Young," incorporating over 15 years of research on cellular wellness and aging. Originally published in 2011, the book challenges the notion that aging is solely determined by genetics, emphasizing that how our genes function is crucial to healthspan—the years spent in good health. It quickly gained popularity, achieving #2 on The New York Times Best Seller List and topping various other bestseller charts.
The updated edition reflects significant advancements in aging science, emphasizing that aging is influenced by biological processes that can be modified. Dr. Chang asserts, "Aging is biology in motion, and biology can be influenced," which is central to the paradigm shift in wellness towards measurable health metrics. This edition features expanded discussions on cellular resilience, oxidative stress management, and the importance of measurable biomarkers for health optimization.
Dr. Chang's insights were pivotal for the development of Nu Skin's Prysm iO platform, which quantifies nutritional health through non-invasive measurements, offering users objective data on their biological age and cellular function. Nu Skin's president and CEO, Ryan Napierski, highlighted the timeliness of this relaunch, showcasing how Dr. Chang's work aligns with the company's mission to lead in intelligent beauty and wellness through evidence-based innovation.
"The Aging Myth" is now available digitally for $9.99, providing readers with a scientific foundation to navigate the future of intelligent beauty and wellness while fostering healthier aging through informed choices.
MWN-AI** Analysis
The relaunch of Dr. Joseph Chang's updated edition of "The Aging Myth" is a notable event for Nu Skin Enterprises Inc. (NYSE: NUS), beckoning investors to take stock of the company's strategic positioning in the health and wellness sector. With approximately 15 additional years of research underscoring the scientific premise that aging is malleable, Nu Skin is poised to leverage its innovative products and the evolving consumer focus on wellness quality.
This edition's emphasis on measurable biology and cellular wellness aligns well with the growing trend toward personalized health solutions. The integration of the Prysm iO platform, which delivers intelligent insights into health status, highlights Nu Skin's commitment to science-backed wellness. This may enhance brand loyalty and attract health-conscious consumers, creating a dual growth path for the company's personal care and nutritional segments.
From a market perspective, Nu Skin’s market cap stands at around $4 billion, and with the potential to expand its reach, particularly in the wellness and beauty sectors, there’s an opportunity for value appreciation. The relaunch of "The Aging Myth" not only serves to reinforce Nu Skin's innovative image but also to underpin its product offerings, potentially driving sales growth.
Investors should monitor the reception of this updated book and the subsequent impact on Nu Skin's sales performance and consumer engagement. Given the success of the original book and its #1 bestseller status across various platforms, this new edition could drive significant market interest, especially as health remains a critical concern post-pandemic.
In conclusion, while keeping an eye on broader market conditions and competitive dynamics, investors may consider Nu Skin as a compelling buy option in the beauty and wellness sector, using Dr. Chang's latest insights as a catalyst for growth in the coming quarters.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
The updated edition of the New York Times bestseller from the chair of the Nu Skin Scientific Advisory Board reveals latest science behind measurable biology and evidence-based longevity
Nu Skin Enterprises Inc. (NYSE: NUS) today announced the relaunch of “The Aging Myth: Unlocking the Mysteries of Looking and Feeling Young,” the updated edition of the bestselling book from Dr. Joseph Chang, chair of Nu Skin’s Scientific Advisory Board. The relaunch marks a significant milestone in the evolution of evidence-based beauty and wellness, bringing together decades of research that underpin Nu Skin’s science-led innovations — from ageLOC® technology to the company’s intelligent beauty and wellness platform centered on Prysm iO ™.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260206515806/en/
Dr. Joseph Chang of Nu Skin with his relaunched bestselling book, The Aging Myth. Many of the discoveries in his new book were instrumental in the development of the Prysm iO intelligent wellness platform.
Originally published in 2011, "The Aging Myth" challenged conventional wisdom by proving that aging isn't about genetic destiny, but about how our genes function. It helps readers understand the science behind their healthspan, or the number of healthy years they live. As people live longer, the concept of wellness is becoming focused on the quality of health during those years. The book quickly became a hit, reaching #2 on The New York Times Best Seller List in its first week and securing the #1 spot at Barnes & Noble, and top rankings on Amazon, Borders and The Wall Street Journal best seller lists.
"The fundamental premise remains unchanged: we are not prisoners of our genetics," said Dr. Chang. "However, the science of aging has evolved tremendously since 2011. This updated edition reflects over 15 years of additional research that continues to validate our core message: aging is biology in motion, and biology can be influenced. When wellness becomes measurable, it transforms from rhetoric into science."
The new edition builds on the original by featuring expanded chapters on cellular resilience, oxidative stress management and the role of measurable biomarkers in health optimization. The updated content addresses how modern technology enables individuals to move beyond subjective feelings about health to objective, measurable insights about their biological age and cellular function. Dr. Chang draws from his experience guiding Nu Skin's quarter-century commitment to evidence-driven wellness research, including breakthrough technologies like the Prysm iO intelligent wellness platform, a non-invasive skin carotenoid measurement device, which provides intelligent insights into an individual’s nutritional health.
"For years, Dr. Chang’s work has guided Nu Skin’s commitment to evidence-based innovation," said Ryan Napierski, president and CEO. "What makes this relaunch so timely is how closely the research aligns with where Nu Skin is today as we work toward our vision to become the world’s leading intelligent beauty and wellness platform. This updated edition shows how the concepts introduced more than a decade ago have matured into a fully realized ecosystem — one where intelligent devices, targeted nutrition and personalized insights work together to support healthier aging. We believe this book provides the scientific foundation for the next decade of intelligent beauty and wellness.”
The digital edition of "The Aging Myth" is available through Amazon Kindle and other major online book retailers beginning today for $9.99.
About The Author
Joseph Y. Chang, Ph.D., was appointed chair of the Nu Skin Scientific Advisory Board in 2024. Prior to that, he served as Nu Skin's chief scientific officer and executive vice president of product development for 18 years. A prolific author, Dr. Chang has published numerous articles, reviews and books on pharmacological research, including the New York Times best seller, The Aging Myth. With over 35 years of experience in the pharmaceutical and dietary supplement industries, Joe enjoys a comprehensive knowledge of both industries. Prior to the acquisition of Pharmanex by Nu Skin Enterprises in 1998, he served as the vice president of clinical studies and pharmacology at Pharmanex.
He has also held various research management positions at Wyeth-Ayerst, Rhone Poulenc Rorer and other biotechnology companies, where he was involved in researching natural products for arthritis and immunosuppressive treatment. He received a B.S. degree from Portsmouth University and a Ph.D. from the University of London.
About Nu Skin Enterprises Inc.
The Nu Skin Enterprises Inc. (NYSE: NUS) family of companies includes Nu Skin and Rhyz Inc. Nu Skin is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with brands including Nu Skin® personal care, Pharmanex® nutrition and ageLOC® anti-aging, which includes an award-winning line of beauty and wellness device systems. Formed in 2018, Rhyz is a synergistic ecosystem of consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260206515806/en/
Media: media@nuskin.com , (801) 345-6397
Investors: investorrelations@nuskin.com , (801) 345-3577
FAQ**
How does the updated edition of "The Aging Myth" align with Nu Skin Enterprises Inc. NUS's overall strategy to position itself as a leader in the evidence-based beauty and wellness market?
What specific advancements in the science of aging have been highlighted in the updated edition of "The Aging Myth," and how do they relate to Nu Skin Enterprises Inc. NUS's product offerings?
How does the launch of the Prysm iO intelligent wellness platform complement the findings presented in "The Aging Myth," and what impact could this have on Nu Skin Enterprises Inc. NUS's growth trajectory?
In what ways does Dr. Joseph Chang's extensive background influence the credibility of the claims made in "The Aging Myth," particularly concerning Nu Skin Enterprises Inc. NUS's research and development initiatives?
**MWN-AI FAQ is based on asking OpenAI questions about Nu Skin Enterprises Inc. (NYSE: NUS).
NASDAQ: NUS
NUS Trading
3.32% G/L:
$7.47 Last:
117,789 Volume:
$7.39 Open:
